Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood

被引:368
作者
Weihrauch-Blueher, Susann [1 ]
Schwarz, Peter [2 ,3 ]
Klusmann, Jan-Henning [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Pediat 1, Halle, Germany
[2] Tech Univ Dresden, Dept Prevent & Care Diabet, Dresden, Germany
[3] Paul Langerhans Inst Dresden, German Ctr Diabet Res DZD, Dresden, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2019年 / 92卷
关键词
Childhood obesity; Adolescent obesity; Puberty; Prevention; Therapy; Cardiometabolic disease; Type; 2; diabetes; Cancer risk; BODY-MASS INDEX; ACUTE MYELOID-LEUKEMIA; COUNTRY-OF-ORIGIN; EUROPEAN CODE; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; MATERNAL SMOKING; WEIGHT-GAIN; LIFE-COURSE;
D O I
10.1016/j.metabol.2018.12.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prevalence of childhood obesity has worldwide more than doubled since 1980. Underlying factors are complex and are far from completely understood. Strategies to prevent childhood obesity have mainly focused on behavioral intervention: and obesity therapy was mainly based on lifestyle modification to date. However, effects for both have been quite limited so far and no country has succeeded in fighting the obesity epidemy we are facing. Normalization of body weight before onset of puberty is crucial for several reasons: First, obese children and adolescents frequently stay obese until adulthood. Second. obesity during adolescence is significantly associated with increased risk for cardiovascular and metabolic disease such as type 2 diabetes in adulthood. And third, recent data have shown a strong association between higher body mass index (BMI) during adolescence and increased risk for several malignancies such as leukemia, Hodgkin's disease, colorectal cancer, breast cancer and others in adulthood. This review summarizes our current understanding of epidemiology, underlying factors, concomitant disease, as well as available intervention strategies and gives an overview of what has been reached so far and what measures should be undertaken to counteract the obesogenic environment (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 94 条
[1]   The duration of obesity and the risk of type 2 diabetes [J].
Abdullah, Asnawi ;
Stoelwinder, Johannes ;
Shortreed, Susan ;
Wolfe, Rory ;
Stevenson, Christopher ;
Walls, Helen ;
de Courten, Maximilian ;
Peeters, Anna .
PUBLIC HEALTH NUTRITION, 2011, 14 (01) :119-126
[2]   Health Effects of Overweight and Obesity in 195 Countries over 25 Years [J].
Afshin, Ashkan ;
Forouzanfar, Mohammad H. ;
Reitsma, Marissa B. ;
Sur, Patrick ;
Estep, Kara ;
Lee, Alex ;
Marczak, Laurie ;
Mokdad, Ali H. ;
Moradi-Lakeh, Maziar ;
Naghavi, Mohsen ;
Salama, Joseph S. ;
Vos, Theo ;
Abate, Kalkidan H. ;
Abbafati, Cristiana ;
Ahmed, Muktar B. ;
Al-Aly, Ziyad ;
Alkerwi, Ala'a ;
Al-Raddadi, Rajaa ;
Amare, Azmeraw T. ;
Amberbir, Alemayehu ;
Amegah, Adeladza K. ;
Amini, Erfan ;
Amrock, Stephen M. ;
Anjana, Ranjit M. ;
Arnlov, Johan ;
Asayesh, Hamid ;
Banerjee, Amitava ;
Barac, Aleksandra ;
Baye, Estifanos ;
Bennett, Derrick A. ;
Beyene, Addisu S. ;
Biadgilign, Sibhatu ;
Biryukov, Stan ;
Bjertness, Espen ;
Boneya, Dube J. ;
Campos-Nonato, Ismael ;
Carrero, Juan J. ;
Cecilio, Pedro ;
Cercy, Kelly ;
Ciobanu, Liliana G. ;
Cornaby, Leslie ;
Damtew, Solomon A. ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dharmaratne, Samath D. ;
Duncan, Bruce B. ;
Eshrati, Babak ;
Esteghamati, Alireza ;
Feigin, Valery L. ;
Fernandes, Joao C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (01) :13-27
[3]   European Code against Cancer 4th Edition: Obesity, body fatness and cancer [J].
Anderson, Annie S. ;
Key, Timothy J. ;
Norat, Teresa ;
Scoccianti, Chiara ;
Cecchini, Michele ;
Berrino, Franco ;
Boutron-Ruault, Marie-Christine ;
Espina, Carolina ;
Leitzmann, Michael ;
Powers, Hilary ;
Wiseman, Martin ;
Romieu, Isabelle .
CANCER EPIDEMIOLOGY, 2015, 39 :S34-S45
[4]  
[Anonymous], LANCET, DOI DOI 10.1016/S0140-6736(17)32129-3
[5]  
[Anonymous], 2012, NAT REV ENDOCRINOL, DOI DOI 10.1038/nrendo.2011.232
[6]  
[Anonymous], Global action plan for the prevention and control of noncommunicable diseases 20132020
[7]   Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study [J].
Astrup, Arne ;
Rossner, Stephan ;
Van Gaal, Luc ;
Rissanen, Aila ;
Niskanen, Leo ;
Al Hakim, Mazin ;
Madsen, Jesper ;
Rasmussen, Mads F. ;
Lean, Michael E. J. .
LANCET, 2009, 374 (9701) :1606-1616
[8]   Childhood body-mass index and the risk of coronary heart disease in adulthood [J].
Baker, Jennifer L. ;
Olsen, Lina W. ;
Sorensen, Thorkild I. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (23) :2329-2337
[9]   Health Consequences of Obesity [J].
Berenson, Gerald S. .
PEDIATRIC BLOOD & CANCER, 2012, 58 (01) :117-121
[10]  
Bjerregaard LG, 2018, NEW ENGL J MED, V378, P1302, DOI [10.1056/NEJMoa1713231, 10.1056/nejmoa1713231]